A director at Thai Vegetable Oil Plc sold 800,000 shares at 25.250THB and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
THAI VEGETABLE OIL (TH), a company active in the Food Products industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date March 1, 2022, the closing price was THB 32.50 and its potential was estimated ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
GREATER CHINA Strategy Alpha Picks: Jun 21 Conviction Calls: Macro uncertainties drive shift to defensive bias. INDONESIA Strategy Alpha Picks: Add ITMG and TLKM: We add ITMG and TLKM to our portfolio. Our picks: ITMG, TLKM, BMRI, KLBF, ASII, BSDE, UNTR, INTP and BEST. MALAYSIA Strategy Alpha Picks: Keeping Faith In Event Catalysts: May 21’s alpha picks portfolio underperformed the FBMKLCI, dragged by Scomnet; Jun 21 picks: HAPL, Inari, Mr DIY, Press Metal and Yinson. SINGAPORE Strategy Alpha...
GREATER CHINA Results JD.com (JD US/BUY/US$68.21/Target: US$100.00): 1Q21: Strong growth momentum, heavier new business investments down the road. NetEase (NTES US/HOLD/US$104.90/Target: US$110.00): 1Q21: In-line results; online games growth to pick up in 2H21. Upgrade to HOLD. Trip.com (TCOM US/BUY/US$38.92/Target: US$52.00): 1Q21: Better-than-expected results; solid 2Q guidance. INDONESIA Update Bank Central Asia (BBCA IJ/HOLD/Rp31,725/Target: Rp32,500): 20bp yoy NIM decline; expecting only 8...
KEY HIGHLIGHTS Results Srisawad Corp (SAWAD TB/HOLD/Bt72.25/Target: Bt69.00) 1Q21: Results were slightly below our expectation on lower investment gains. Thai Vegetable Oil (TVO TB/BUY/Bt36.00/Target: Bt44.00) 1Q21: Very impressive earnings. Update Bangkok Expressway and Metro (BEM TB/BUY/Bt7.70/Target: Bt10.20) The containment of the COVID-19 pandemic as well as COVID-19 inoculation will lead to a recovery from 2H21 onwards. Central Pattana (CPN TB/BUY/Bt50.00/Target: Bt62.00) Temporary st...
GREATER CHINA Strategy Alpha Picks: Greater China April Conviction List: The recent market pullback is a good window to accumulate stocks with a strong earnings outlook. We are adding 12 stocks − including Li Ning, Haidilao, JD.com and Trip.com − to our BUY list. INDONESIA Strategy Alpha Picks: Underperformed In A Weak Market: We decided to reduce exposure to the construction sector by dropping WSKT. Our picks are: KLBF, BMRI, BSDE, WIKA, UNTR, INTP, ASII and BBTN. MALAYSIA Strategy Alpha Pick...
GREATER CHINA Sector Consumer: Bi-weekly (18 Feb-2 Mar 21) update. Education: AST: The art of defence. INDONESIA Strategy Alpha Picks: Adding ASII, BBTN and INTP: We add ASII, BBTN and INTP but drop SMRA and BBNI; our picks: BBTN, KLBF, BMRI, BSDE, WIKA, WSKT, UNTR, ASII and INTP. Results PP London Sumatra (LSIP IJ/HOLD/Rp1,300.00/Target: Rp1,300.00): 2020: Results came in above our and consensus’ forecasts, with 4Q20 earnings coming in stronger than market expectation. Expect LSIP to continue ...
KEY HIGHLIGHTS Update Charoen Pokphand Foods (CPF TB/HOLD/Bt28.50/Target: Bt28.75) Less exciting earnings in 2021. Thai Vegetable Oil (TVO TB/BUY/Bt35.25/Target: Bt44.00) Expect strong earnings in 2021. True Corporation (TRUE TB/BUY/Bt3.48/Target: Bt4.00) 4Q20 results preview: Expect lower qoq core operating loss.
GREATER CHINA Economics Unpleasant Arithmetic: Even with a fiscal deficit target of 3% of GDP, our projections suggest that overall debt could still rise to 278.5% of GDP; funding stress remains a key risk for 2021. INDONESIA Small/Mid Cap Highlights Indika Energy (INDY IJ/NOT RATED/Rp1,790): Consensus expects 11% yoy EBITDA growth in 2021. MALAYSIA Update Pentamaster Corporation (PENT MK/BUY/RM5.70/Target: RM6.40): Structural growth from next-generation technologies is accelerating, especiall...
GREATER CHINA Sector Aviation: Airlines and logistics firms among key beneficiaries of COVID-19 vaccine distribution. Results JD.com (JD US/BUY/US$92.08/Target: US$105.00): 3Q20: Solid earnings beat; committed to investing in logistics for grocery categories. Update Baosteel (600019 CH/BUY/Rmb6.54/Target: Rmb8.62): Demand supports earnings recovery; upgrade to BUY. INDONESIA Update Merdeka Copper Gold (MDKA IJ/SELL/Rp1,860/Target: Rp1,400): Bloomberg consensus cut 2021 gold price forecast by 10...
KEY HIGHLIGHTS Results Diamond Building Products (DRT TB/HOLD/Bt6.05/Target: Bt5.50) 3Q20: Posts lower yoy earnings. However, cost savings, a better economy and a stronger focus on sales channels will allow DRT to see moderate earnings growth next year. Sino-Thai Engineering & Construction (STEC TB/BUY/Bt12.10/Target: Bt14.00) 3Q20: Earnings continued to decline on lower sales despite stabilising margins. Thai Vegetable Oil (TVO TB/BUY/Bt33.00/Target: Bt39.00) 3Q20: Net profit declines 6%...
GREATER CHINA Sector Consumer: Promising catalysts for National Day Golden Week. Update BYD (1211 HK/BUY/HK$104.90/Target: HK$150.00): Upgrade target price from HK$95.00 to HK$150.00 on promising EV battery business. INDONESIA Strategy Vaccine for COVID-19 – The Global Game Changer: A positive outcome of COVID-19 vaccines currently undergoing Phase 3 clinical trials could happen before the end of 2020. MALAYSIA Results Kim Loong Resources (KIML MK/HOLD/RM1.39/Target: RM1.30): Results within ex...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.